ORG Partners LLC Takes $908,000 Position in Axon Enterprise, Inc (NASDAQ:AXON)

ORG Partners LLC bought a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,678 shares of the biotechnology company's stock, valued at approximately $908,000.

Other institutional investors have also added to or reduced their stakes in the company. Pinion Investment Advisors LLC boosted its holdings in shares of Axon Enterprise by 3.0% in the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock worth $341,000 after purchasing an additional 19 shares in the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after purchasing an additional 21 shares in the last quarter. Beacon Pointe Advisors LLC boosted its holdings in shares of Axon Enterprise by 2.6% in the 4th quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company's stock worth $513,000 after purchasing an additional 22 shares in the last quarter. Transcend Capital Advisors LLC boosted its holdings in shares of Axon Enterprise by 3.6% in the 4th quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company's stock worth $431,000 after purchasing an additional 25 shares in the last quarter. Finally, Fielder Capital Group LLC boosted its holdings in shares of Axon Enterprise by 2.2% in the 4th quarter. Fielder Capital Group LLC now owns 1,176 shares of the biotechnology company's stock worth $699,000 after purchasing an additional 25 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Bank of America increased their target price on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. The Goldman Sachs Group increased their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Barclays increased their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Finally, Needham & Company LLC increased their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Trading Up 0.8%

NASDAQ AXON traded up $6.53 on Friday, hitting $777.32. The company's stock had a trading volume of 1,181,999 shares, compared to its average volume of 476,402. Axon Enterprise, Inc has a 52-week low of $279.02 and a 52-week high of $806.64. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The company's 50-day simple moving average is $692.15 and its 200 day simple moving average is $626.13. The firm has a market cap of $60.51 billion, a P/E ratio of 187.76, a PEG ratio of 88.73 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same quarter last year, the business posted $1.15 EPS. The business's revenue was up 31.3% on a year-over-year basis. Research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Activity

In other news, President Joshua Isner sold 905 shares of the firm's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $776.39, for a total value of $702,632.95. Following the completion of the transaction, the president now owns 268,735 shares in the company, valued at $208,643,166.65. This trade represents a 0.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the completion of the transaction, the chief accounting officer now owns 15,240 shares of the company's stock, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 in the last quarter. 4.40% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.